Suppr超能文献

神经肌肉阻滞剂的年龄特异性药理学:全面综述

Age-Specific Pharmacology of Neuromuscular Blocking Agents: A Comprehensive Review.

作者信息

Radkowski Paweł, Kowalczyk Kacper, Łęczycka Anna, Oniszczuk Hubert, Grabarczyk Łukasz

机构信息

Department of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.

Department of Anaesthesiology and Intensive Care, Regional Specialist Hospital in Olsztyn, Olsztyn, Poland.

出版信息

Med Sci Monit. 2025 Sep 29;31:e949656. doi: 10.12659/MSM.949656.

Abstract

Neuromuscular blocking agents (NMBAs) are essential in anesthesia, used primarily for intubation and synchronizing mechanical ventilation. They can be divided into depolarizing and non-depolarizing agents with an addition of reversal agents, which can be used to avoid residual muscle blockade. Their pharmacological properties vary among age groups due to physiological differences. In children, immature liver and kidney function, body composition, and immature neuromuscular junction influence drug properties. Elderly patients tend to have reduced organ function, more comorbidities, and greater vulnerability to stress. Ensuring anesthesia safety and preventing complications often requires adjusting doses and delivery regimens, which can be problematic, especially among inexperienced anesthesia personnel. To address this issue, we created this review to clarify dosage differences and their physiological bases. The article provides an overview of numerous clinical studies, including recent ones conducted on age-diverse patient populations, which, combined with an explanation of the pharmacological basis of NMBAs, is a valuable resource for anesthesiology with various levels of experience. The manuscript was based on 131 articles dating from 1987 to 2025, as well as the authors' knowledge and clinical experience.

摘要

神经肌肉阻滞剂(NMBAs)在麻醉中至关重要,主要用于气管插管和机械通气同步。它们可分为去极化和非去极化剂,还可加用逆转剂以避免残余肌松。由于生理差异,其药理特性在不同年龄组有所不同。在儿童中,肝肾功能不成熟、身体组成以及神经肌肉接头不成熟会影响药物特性。老年患者往往器官功能减退、合并症更多且对应激更脆弱。确保麻醉安全和预防并发症通常需要调整剂量和给药方案,这可能存在问题,尤其是在经验不足的麻醉人员中。为解决这一问题,我们撰写了本综述以阐明剂量差异及其生理基础。本文概述了众多临床研究,包括近期针对不同年龄患者群体开展的研究,结合对NMBAs药理基础的解释,对于不同经验水平的麻醉学来说都是宝贵资源。该文稿基于1987年至2025年的131篇文章以及作者的知识和临床经验撰写而成。

本文引用的文献

4
Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review.
Med Sci Monit. 2025 Jan 1;31:e945822. doi: 10.12659/MSM.945822.
6
Sugammadex for our little ones: a brief narrative review.
Anesth Pain Med (Seoul). 2024 Oct;19(4):269-279. doi: 10.17085/apm.24092. Epub 2024 Oct 31.
8
The Dosage of Muscle Relaxants in Morbidly Obese Patients in Daily Practice - A Narrative Review.
Int J Gen Med. 2024 Sep 14;17:4055-4060. doi: 10.2147/IJGM.S474221. eCollection 2024.
9
Navigating Anesthesia: Muscle Relaxants and Reversal Agents in Patients with Renal Impairment.
Med Sci Monit. 2024 Aug 27;30:e945141. doi: 10.12659/MSM.945141.
10
Eliminating residual neuromuscular blockade: a literature review.
Ann Transl Med. 2024 Aug 1;12(4):65. doi: 10.21037/atm-23-1743. Epub 2024 May 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验